Reaction Details |
| Report a problem with these data |
Target | Oxysterols receptor LXR-beta |
---|
Ligand | BDBM115098 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response screening assay to identify agonists of the Liver-X-Receptor (LXR) |
---|
EC50 | 67615±n/a nM |
---|
Citation | PubChem, PC Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response screening assay to identify agonists of the Liver-X-Receptor (LXR) PubChem Bioassay(2013)[AID] |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
Oxysterols receptor LXR-beta |
---|
Name: | Oxysterols receptor LXR-beta |
Synonyms: | LXRB | Liver X receptor beta (NR1H2) | Liver X, LXR beta | NER | NR1H2 | NR1H2_HUMAN | Nuclear receptor NER | UNR | Ubiquitously-expressed nuclear receptor |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 50978.79 |
Organism: | Homo sapiens (Human) |
Description: | P55055 |
Residue: | 460 |
Sequence: | MSSPTTSSLDTPLPGNGPPQPGAPSSSPTVKEEGPEPWPGGPDPDVPGTDEASSACSTDW
VIPDPEEEPERKRKKGPAPKMLGHELCRVCGDKASGFHYNVLSCEGCKGFFRRSVVRGGA
RRYACRGGGTCQMDAFMRRKCQQCRLRKCKEAGMREQCVLSEEQIRKKKIRKQQQESQSQ
SQSPVGPQGSSSSASGPGASPGGSEAGSQGSGEGEGVQLTAAQELMIQQLVAAQLQCNKR
SFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQI
ALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMR
RLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRM
LMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE
|
|
|
BDBM115098 |
---|
n/a |
---|
Name | BDBM115098 |
Synonyms: | 2-(1-ethylsulfanyl-2-methyl-propan-2-yl)-1H-indazol-3-one | 2-(1-ethylsulfanyl-2-methylpropan-2-yl)-1H-indazol-3-one | 2-[1-(ethylthio)-2-methylpropan-2-yl]-1H-indazol-3-one | 2-[2-(ethylthio)-1,1-dimethyl-ethyl]indazolin-3-one | MLS003151649 | SMR001856244 | cid_46904954 |
Type | Small organic molecule |
Emp. Form. | C13H18N2OS |
Mol. Mass. | 250.36 |
SMILES | CCSCC(C)(C)n1[nH]c2ccccc2c1=O |
Structure |
|